Digest Network Come funziona
Network
/
Società
Me
Non verificato

Merck

Di cosa scriviamo

BiotecnologiaFarmaceuticaIndustriaMedicina - VarieSalute

34 comunicati stampa

Guarda tutti i comunicati
21/04/2026
Annunci Economici
Merck Launches First Bio-Based Solvent Portfolio for High-Performance Liquid Chromatography
Fonte
Merck
Emittente
GLOBENEWSWIRE
1.00
0
01/04/2026
Annunci Economici
Merck Completes Acquisition of JSR Life Sciences’ Chromatography Business, Expanding Protein A Capabilities and Downstream Portfolio
Fonte
Merck
Emittente
GLOBENEWSWIRE
1.00
0
18/03/2026
Annunci Economici
Merck Marks 10 Years of SPARK™ Mobilizing Employee Volunteers to Help Inspire the Next Generation in STEM
Fonte
Merck
Emittente
GLOBENEWSWIRE
1.00
0
12/01/2026
Eventi
Industria
Salute
Farmaceutica
Medicina - Varie
Oncologia
FDA Accepts New Drug Application for Pimicotinib for the Treatment of Tenosynovial Giant Cell Tumor
Fonte
Merck
Emittente
Business Wire
1.00
0
12/01/2026
Eventi
Industria
Salute
Farmaceutica
Medicina - Varie
Oncologia
FDA Accepts New Drug Application for Pimicotinib for the Treatment of Tenosynovial Giant Cell Tumor
Fonte
Merck
Emittente
Business Wire
1.00
0
22/12/2025
Oncologia
Auto/Automotive
Salute
Sanità
Farmaceutica
Industria
Pimicotinib Approved as Systemic Treatment in China for Tenosynovial Giant Cell Tumor
Fonte
Merck
Emittente
Business Wire
1.00
0
24/11/2025
Industria
Attrezzature medico-sanitarie
Salute
Sanità
Medicina - Varie
Farmaceutica
Merck Takes Patient-Directed Approach to Bring Innovation to the Treatment of Rare Neuromuscular Disorder, Generalized Myasthenia Gravis
Fonte
Merck
Emittente
Business Wire
1.00
0
28/10/2025
Merck Partners with Promega to Advance 3-D Cell Drug Discovery Technologies
Fonte
Merck
Emittente
Business Wire
1.00
0
17/10/2025
Oncologia
Salute
Sanità
Medicina - Varie
Farmaceutica
Biotecnologia
Industria
Pimicotinib Treatment Demonstrates Deep and Durable Tumor Responses and Continued Improvements in Pain and Function for Patients with TGCT
Fonte
Merck
Emittente
Business Wire
1.00
0
15/10/2025
Merck to Acquire the Chromatography Business of JSR Life Sciences, Expanding Protein A Capabilities and Downstream Portfolio
Fonte
Merck
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0